![Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation” - Journal of the American Academy of Dermatology Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation” - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c8586823-e118-4464-a9b3-ab144819fe57/gr1_lrg.jpg)
Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation” - Journal of the American Academy of Dermatology
![PDF) Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment PDF) Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment](https://i1.rgstatic.net/publication/344384491_Efficacy_and_Safety_of_Oral_Minoxidil_5_mg_Once_Daily_in_the_Treatment_of_Male_Patients_with_Androgenetic_Alopecia_An_Open-Label_and_Global_Photographic_Assessment/links/600cfcc445851553a0679a57/largepreview.png)
PDF) Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment
Dr. Sergio Vañó on Twitter: "Treatment of male #AndrogeneticAlopecia with oral dutasteride and low dose oral minoxidil. 💊 💊 Early response after 4 months. ➡️ No adverse effects were detected! #tricoHRC #tricologiaGPJ #
![PDF) Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation” PDF) Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation”](https://i1.rgstatic.net/publication/335764203_Reply_to_Very-low-dose_oral_minoxidil_in_male_androgenetic_alopecia_A_study_with_quantitative_trichoscopic_documentation/links/5e6e6acb92851c6ba706407c/largepreview.png)
PDF) Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation”
![Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia - Journal of the American Academy of Dermatology Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/77b17e99-c571-4d0c-a64a-d407cc11eea5/gr1_lrg.jpg)
Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia - Journal of the American Academy of Dermatology
![Platelet‐rich plasma with low dose oral minoxidil (1.25mg versus 2.5mg) along with trichoscopic pre‐ and post‐treatment evaluation - Jha - 2021 - Journal of Cosmetic Dermatology - Wiley Online Library Platelet‐rich plasma with low dose oral minoxidil (1.25mg versus 2.5mg) along with trichoscopic pre‐ and post‐treatment evaluation - Jha - 2021 - Journal of Cosmetic Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/da92bb0c-dd46-4602-9d24-4d725ee3e5f4/jocd14049-fig-0001-m.jpg)
Platelet‐rich plasma with low dose oral minoxidil (1.25mg versus 2.5mg) along with trichoscopic pre‐ and post‐treatment evaluation - Jha - 2021 - Journal of Cosmetic Dermatology - Wiley Online Library
![Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation - Journal of the American Academy of Dermatology Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1a0f6891-374e-4102-81d3-aa40c5b00e96/gr1_lrg.jpg)